Weekly medications for the treatment of type 2 diabetes, such as GLP-1 receptor agonists like Bydureon, Trulicity, and Ozempic, are often added to current therapy if it is not effectively controlling blood sugar levels. These medications have additional benefits, especially on cardiovascular health, and are usually well-tolerated when started at a low dose and gradually increased based on effectiveness and tolerance. They are covered by public insurance under specific conditions for type 2 diabetes treatment. It is recommended to discuss these options with a pharmacist, who can assess if this type of therapy would be suitable for you and communicate recommendations to your doctor if needed. Feel free to ask if you have any further questions.